Identity
- Security key
- 15272
- Ticker
- FENC
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2002-01-28
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- FENC
Detail
Enriched 2026-08-14 20:47
- Market cap
- $414,452,220
- Shares outstanding (class)
- 35,058,266
- Shares outstanding (weighted)
- 35,034,000
- SIC
- 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
- Employees
- 35
- Location
- RESEARCH TRIANGLE PARK, NC
- Homepage
- https://www.fennecpharma.com
- Description
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.